Literature DB >> 26047604

The relationship between telomere length and clinicopathologic characteristics in colorectal cancers among Tunisian patients.

Raja Mzahma1, Maher Kharrat1, Fadhel Fetiriche2, Mounir Ben Moussa3, Zoubeir Ben Safta2, Chadli Dziri4, AbdelJelil Zaouche3, Habiba Chaabouni-Bouhamed5,6.   

Abstract

Alterations in telomere dynamics have emerged as having a causative role in carcinogenesis. Both the telomere attrition contribute to tumor initiation via increasing chromosomal instability and that the telomere elongation induces cell immortalization and leads to tumor progression. The objectives of this study are to investigate the dynamics of telomere length in colorectal cancer (CRC) and the clinicopathological parameters implicated. We measured the relative telomere length (RTL) in cancerous tissues and in corresponding peripheral blood leukocytes (PBL) using quantitative PCR (Q-PCR) from 94 patients with CRC. Telomere length correlated significantly in cancer tissues and corresponding PBL (r = 0.705). Overall, cancer tissue had shorter telomeres than PBL (p = 0.033). In both cancer tissue and PBL, the RTL was significantly correlated with age groups (p = 0.008 and p = 0.012, respectively). The RTL in cancer tissue was significantly longer in rectal tumors (p = 0.04) and in the late stage of tumors (p = 0.01). In PBL, the RTL was significantly correlated with the macroscopic aspect of tumors (p = 0.02). In addition, the telomere-length ratio of cancer to corresponding PBL increased significantly with late-stage groups. Shortening of the telomere was detected in 44.7%, elongation in 36.2%, and telomeres were unchanged in 19.1% of 94 tumors. Telomere shortening occurred more frequently in the early stage of tumors (p = 0.01). This study suggests that the telomere length in PBL is affected by the macroscopic aspect of tumors and that telomere length in cancer tissues is a marker for progression of CRC and depends on tumor-origin site.

Entities:  

Keywords:  Clinicopathologic characteristics; Colorectal cancer; Telomere length

Mesh:

Substances:

Year:  2015        PMID: 26047604     DOI: 10.1007/s13277-015-3545-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  38 in total

Review 1.  Telomeres and human disease: ageing, cancer and beyond.

Authors:  Maria A Blasco
Journal:  Nat Rev Genet       Date:  2005-08       Impact factor: 53.242

2.  Telomere function in colorectal cancer.

Authors:  Cristina Frías; Alberto Morán; Carmen de Juan; Paloma Ortega; Tamara Fernández-Marcelo; Andrés Sánchez-Pernaute; Antonio José Torres; Eduardo Díaz-Rubio; Manuel Benito; Pilar Iniesta
Journal:  World J Gastrointest Oncol       Date:  2009-10-15

3.  Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas.

Authors:  S Takagi; Y Kinouchi; N Hiwatashi; M Chida; F Nagashima; S Takahashi; K Negoro; T Shimosegawa; T Toyota
Journal:  Cancer       Date:  1999-10-15       Impact factor: 6.860

Review 4.  Telomeres, telomerase and cancer: an up-date.

Authors:  K Dhaene; E Van Marck; R Parwaresch
Journal:  Virchows Arch       Date:  2000-07       Impact factor: 4.064

5.  Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.

Authors:  Cristina Garcia-Aranda; Carmen de Juan; Antonio Diaz-Lopez; Andres Sanchez-Pernaute; Antonio-Jose Torres; Eduardo Diaz-Rubio; Jose-Luis Balibrea; Manuel Benito; Pilar Iniesta
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

Review 6.  Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis.

Authors:  Jennifer A Hackett; Carol W Greider
Journal:  Oncogene       Date:  2002-01-21       Impact factor: 9.867

7.  Telomere shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorectal cancer.

Authors:  R R Plentz; S U Wiemann; P Flemming; P N Meier; S Kubicka; H Kreipe; M P Manns; K L Rudolph
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

Review 8.  Telomere-driven genomic instability in cancer cells.

Authors:  Chantal Desmaze; Jean-Charles Soria; Marie-Anne Freulet-Marrière; Noelle Mathieu; Laure Sabatier
Journal:  Cancer Lett       Date:  2003-05-15       Impact factor: 8.679

Review 9.  Telomerase and tumorigenesis.

Authors:  Kenkichi Masutomi; William C Hahn
Journal:  Cancer Lett       Date:  2003-05-15       Impact factor: 8.679

10.  Telomere length changes in colorectal cancers and polyps.

Authors:  Hyeong Rok Kim; Young Jin Kim; Hyun Jong Kim; Shin Kon Kim; Ji Hee Lee
Journal:  J Korean Med Sci       Date:  2002-06       Impact factor: 2.153

View more
  3 in total

1.  Association of circulating leukocyte telomere length with survival in patients with colorectal cancer.

Authors:  Svenja Pauleck; Biljana Gigic; Richard M Cawthon; Jennifer Ose; Anita R Peoples; Christy A Warby; Jennifer A Sinnott; Tengda Lin; Juergen Boehm; Petra Schrotz-King; Christopher I Li; David Shibata; Erin M Siegel; Jane C Figueiredo; Adetunji T Toriola; Martin Schneider; Alexis B Ulrich; Albrecht Hoffmeister; Cornelia M Ulrich; Sheetal Hardikar
Journal:  J Geriatr Oncol       Date:  2022-01-05       Impact factor: 3.929

2.  Clinical Relevance of Telomere Status and Telomerase Activity in Colorectal Cancer.

Authors:  Tamara Fernández-Marcelo; Andrés Sánchez-Pernaute; Irene Pascua; Carmen De Juan; Jacqueline Head; Antonio-José Torres-García; Pilar Iniesta
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

Review 3.  A Review of Cancer Genetics and Genomics Studies in Africa.

Authors:  Solomon O Rotimi; Oluwakemi A Rotimi; Bodour Salhia
Journal:  Front Oncol       Date:  2021-02-15       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.